Suppression of human immunodeficiency virus type 1 viral load during acute measles
Moss, W.J.; Scott, S.; Ndhlovu, Z.; Monze, M.; Cutts, F.T.; Quinn, T.C.; Griffin, D.E.
Pediatric Infectious Disease Journal 28(1): 63-65
2009
ISSN/ISBN: 0891-3668 PMID: 19057456 DOI: 10.1097/inf.0b013e318184eed2Document Number: 207986
Acute measles virus infection can result in a transient decrease in plasma human immunodeficiency virus type 1 (HIV-1) RNA loads. We report the kinetics of plasma HIV-1 RNA loads in 2 Zambian children with confirmed and probable measles, and show that the decline in viral load is of similar magnitude to the first-phase decay rate after initiation of antiretroviral therapy.
Document emailed within 0-6 h
Related Documents
Nishida, Y.; Moriya, K.; Nagaizumi, K.; Inaba, H.; Amano, K.; Fukue, H.; Yamamoto, Y.; Arai, M.; Fukutake, K. 2000: Quantitation of human immunodeficiency virus type 1 RNA by ultrasensitive method in the analysis of samples with low viral load Rinsho Byori. Japanese Journal of Clinical Pathology 48(3): 282-283Rousseau, C.M.; Daniels, M.G.; Carlson, J.M.; Kadie, C.; Crawford, H.; Prendergast, A.; Matthews, P.; Payne, R.; Rolland, M.; Raugi, D.N.; Maust, B.S.; Learn, G.H.; Nickle, D.C.; Coovadia, H.; Ndung'u, T.; Frahm, N.; Brander, C.; Walker, B.D.; Goulder, P.J.R.; Bhattacharya, T.; Heckerman, D.E.; Korber, B.T.; Mullins, J.I. 2008: HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load Journal of Virology 82(13): 6434-6446
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Burkhardt, U.; Eggers, H.J. 1993: Viral infections--clinical pictures and laboratory diagnosis. Part 5: Human immunodeficiency virus (HIV 1, HIV 2) to measles virus Fortschritte der Medizin 111(35-36): 559-561
Arpadi, S.M.; Markowitz, L.E.; Baughman, A.L.; Shah, K.; Adam, H.; Wiznia, A.; Lambert, G.; Dobroszycki, J.; Heath, J.L.; Bellini, W.J. 1996: Measles antibody in vaccinated human immunodeficiency virus type 1-infected children Pediatrics 97(5): 653-657
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Schmid, I.; Arrer, E.; Hawranek, T. and Wolfgang Patsch 2000: Evaluation of Two Commercial Procedures for Quantification of Human Immunodeficiency Virus Type 1 RNA With Respect to HIV-1 Viral Subtype and Antiviral Treatment Clinical Laboratory 46(7-8): 355-360
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Farquhar, C.; Wamalwa, D.; Selig, S.; John-Stewart, G.; Mabuka, J.; Majiwa, M.; Sutton, W.; Haigwood, N.; Wariua, G.; Lohman-Payne, B. 2009: Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination Pediatric Infectious Disease Journal 28(4): 295-299
Kessler, H.A.; Blaauw, B.; Spear, J.; Paul, D.A.; Falk, L.A.; Landay, A. 1987: Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome JAMA 258(9): 1196-1199
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Beressi, A.; Sunheimer, R.L.; Huish, S.; Finck, C.; Pincus, M.R. 1994: Acute severe rhabdomyolysis in an human immunodeficiency virus-seropositive patient associated with rising anti-coxsackie B viral titers Annals of Clinical and Laboratory Science 24(3): 278-281
Baba, U.A.; Mustapha, M.G.; Ashir, G.M.; Rabasa, A.I.; Ibrahim, B.A.; Ibrahim, H.A. 2012: Passive measles immunity in a Nigerian tertiary health care facility: the influence of human immunodeficiency virus infection on measles antibody levels in mother-infant pairs at birth West African Journal of Medicine 31(4): 243-246
Donovan, R.M.; Bush, C.E.; Markowitz, N.P.; Baxa, D.M.; Saravolatz, L.D. 1996: Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons Journal of Infectious Diseases 174(2): 401-403
Crumpacker, C.; Heagy, W.; Bubley, G.; Monroe, J.E.; Finberg, R.; Hussey, S.; Schnipper, L.; Lucey, D.; Lee, T.H.; McLane, M.F. 1987: Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation Annals of Internal Medicine 107(5): 664-674
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Okuku, H.Selassie.; Sanders, E.J.; Nyiro, J.; Ngetsa, C.; Ohuma, E.; McClelland, R.Scott.; Price, M.A.; Graham, S.M. 2011: Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior Sexually Transmitted Diseases 38(9): 837-844
Byrd, V.M.; Sergent, J.S. 1996: Suppression of systemic lupus erythematosus by the human immunodeficiency virus Journal of Rheumatology 23(7): 1295-1296